Actuate Therapeutics, Inc. ACTU Q2 2026 earnings

FAQ

When did Actuate Therapeutics, Inc. report Q2 2026 earnings?

Actuate Therapeutics, Inc. (ACTU) reported Q2 2026 earnings on August 14, 2026 before market open.

What were Actuate Therapeutics, Inc.'s Q2 2026 revenue and EPS?

Actuate Therapeutics, Inc. reported eps of $-0.20 for Q2 2026.

Did Actuate Therapeutics, Inc. beat estimates in Q2 2026?

EPS beat the consensus estimate of $-0.21 by $0.01.

How did Actuate Therapeutics, Inc.'s Q2 2026 results compare year-over-year?

Compared to the same quarter a year prior, eps grew 33.3% from $-0.30.

Where can I find Actuate Therapeutics, Inc.'s Q2 2026 SEC filings?

You can read the 10-Q periodic report (0001683168-26-006472) directly on SEC EDGAR. The filing index links above go to sec.gov.